MEN2A

MEN2A (Multiple Endocrine Neoplasia type 2A) is a medical condition that is characterized by the occurrence of medullary thyroid carcinoma, pheochromocytoma, and parathyroid hyperplasia or adenomas. It is a form of Multiple Endocrine Neoplasia (MEN), a group of conditions that affect the body's endocrine system.

Symptoms[edit | edit source]

The symptoms of MEN2A can vary greatly from person to person. Some people may have no symptoms at all, while others may experience severe symptoms. Common symptoms include:

High blood pressure
Rapid heart rate
Sweating
Headaches
Nervousness or anxiety
Frequent urination
Constipation
Weight loss
Fatigue

Causes[edit | edit source]

MEN2A is caused by mutations in the RET proto-oncogene. These mutations are inherited in an autosomal dominant manner, meaning that an affected person has a 50% chance of passing the condition on to each of their children.

Diagnosis[edit | edit source]

The diagnosis of MEN2A is typically made based on a combination of clinical findings and genetic testing. Genetic testing can identify mutations in the RET proto-oncogene that cause MEN2A.

Treatment[edit | edit source]

The treatment for MEN2A typically involves surgery to remove the affected glands. This can often prevent or slow the progression of the disease. Medications may also be used to manage symptoms.

References[edit | edit source]

MEN2A Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.